Enzymedica, a US-based company that provides digestive supplements, announced on Tuesday that it has named Michael Graham as its new vice president of Operations.

In the new role, Graham is to play an important role in optimising the company's supply chain, manufacturing processes and overall operational efficiency.

Graham has earlier worked with Teva Pharmaceuticals and brings a range of operational expertise and strategic leadership to his new role.

Scott Sensenbrenner, Enzymedica CEO, said: "We are excited to welcome Michael Graham to Enzymedica. His proven track record in supply chain and manufacturing, combined with his commitment to quality and efficiency, aligns seamlessly with our mission to provide the highest quality digestive health and wellness supplements to our customers."